University of California, Riverside
The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.
Inclusion Criteria: * Adults 21 years of age or older and not older than 75 recruited from UCR Health * Clinical diagnosis of type II DM with Ha1c \>= 8 but less than or equal to 10 * Stable medications for at least 6 months * Speak Spanish and/or English * Sign an informed consent form * No other members in their household are participating in the study Exclusion Criteria: * Patients \<21 years of age, who do not have type II DM, whose Ha1c is less than 8 or \> 10, * Have major complications of diabetes, including CKD, diabetic retinopathy, ADVD risk \> 5, or history of CVD/stroke * Do not…
In the experimental arm, participants will drink the A1C drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.
In the placebo arm, participants will drink the placebo drink BID for 3 months as instructed. Both the active and placebo drinks will be identical in can size (12 oz slim can), packaging format, and visual appearance.
Arctuva estimate
Verify or correct the compensation shown for this listing.